Ana Benavides

Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer

J. Carles, R. Rosell, A. Abad, 1992, Investigational New Drugs.

Phase I study of mitonafide in solid tumors

A. Ruíz, V. Guillem, V. Soriano, 1992, Investigational New Drugs.

Phase I study of mitonafide with a 3-day administration schedule: Early interruption due to severe central nervous system toxicity

Miguel Martín, E. Díaz-Rubio, A. Casado, 2004, Investigational New Drugs.